Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,512 results
- Treatment of Language and Memory in Patients With Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Language and Memory in Patients With Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593372).
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Treatment of Peripheral T-cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Peripheral T-cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664975).
- Treatment of Prepubertal Labial Adhesions: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Prepubertal Labial Adhesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218463).
- Treatment of Smoking Lapses and Relapses: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Smoking Lapses and Relapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01807871).
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00272844).
- Treatment of the Face and Neck With Lower Ulthera System Energy Settings: Complete Statistical AnalysisIndependent statistical analysis of Treatment of the Face and Neck With Lower Ulthera System Energy Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treatment of Upper Extremity Deep-Vein Thrombosis: Complete Statistical AnalysisIndependent statistical analysis of Treatment of Upper Extremity Deep-Vein Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00245856).
- Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan: Complete Statistical AnalysisIndependent statistical analysis of Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass: Complete Statistical AnalysisIndependent statistical analysis of Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass: primary…
- Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Treatment With AMD3100 (Plerixafor) in Non-Hodgkin’s Lymphoma and Multiple Myeloma Patients: Complete Statistical AnalysisIndependent statistical analysis of Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treatment-Resistant Depression Registry: Complete Statistical AnalysisIndependent statistical analysis of Treatment-Resistant Depression Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00320372).
- Treatment, Pain, and Opioids: Complete Statistical AnalysisIndependent statistical analysis of Treatment, Pain, and Opioids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05363176).
- TREATNOWIndependent statistical analysis of Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372628).
- TREATTIndependent statistical analysis of TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03136445).
- TreeToppIndependent statistical analysis of Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TremelimumabIndependent statistical analysis of Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TrevisioPASIndependent statistical analysis of Trevisio Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04433520).
- TRFIndependent statistical analysis of Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches: Complete Statistical AnalysisIndependent statistical analysis of Trial Comparing Cosmetic Outcomes of Pediatric Laceration Closure Using Skin Glue, Medical Tape Versus Stitches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction: Complete Statistical AnalysisIndependent statistical analysis of Trial Evaluating Postop Pain and Muscle Strength Among Regional Anesthesia Techniques for Ambulatory ACL Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions: Complete Statistical AnalysisIndependent statistical analysis of Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00574587).
- Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT): Complete Statistical AnalysisIndependent statistical analysis of Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00094497).
- Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03225989).
- Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours: Complete Statistical AnalysisIndependent statistical analysis of Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial of Growth Hormone Therapy in Pediatric Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Trial of Growth Hormone Therapy in Pediatric Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00109473).
- Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia: Complete Statistical AnalysisIndependent statistical analysis of Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC: Complete Statistical AnalysisIndependent statistical analysis of Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant: Complete Statistical AnalysisIndependent statistical analysis of Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant: primary endpoint results, effect estimate…
- Trial of Imatinib for Hospitalized Adults With COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Trial of Imatinib for Hospitalized Adults With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04394416).
- Trial of LBH589 in Metastatic Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of LBH589 in Metastatic Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013597).
- Trial of Linaclotide in Patients With Chronic Constipation: Complete Statistical AnalysisIndependent statistical analysis of Trial of Linaclotide in Patients With Chronic Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00730015).
- Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release: Complete Statistical AnalysisIndependent statistical analysis of Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03658304).
- Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors: primary endpoint…
- Trial of NanoPac Focal Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of NanoPac Focal Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04221828).
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL: Complete Statistical AnalysisIndependent statistical analysis of Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…